Company Anygen Co., Ltd.

Equities

A196300

KR7196300008

Pharmaceuticals

End-of-day quote Korea S.E. 06:00:00 2024-05-02 pm EDT 5-day change 1st Jan Change
15,300 KRW 0.00% Intraday chart for Anygen Co., Ltd. -0.07% +4.08%

Business Summary

ANYGEN CO., LTD. is a Korea-based company mainly engaged in manufacture and distribution of peptides. The Company's products mainly consist of leuprorelin acetate, desmopressin acetate, and contract manufacturing organization (CMO) peptides, which are used for pharmaceuticals; custom peptides, which is used for research, and argireline, which is used for cosmetics. The Company distributes its products within domestic market and to overseas markets.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Peptide Biomaterials
100.0 %
8,662 100.0 % 5,611 100.0 % -35.23%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
87.5 %
8,662 100.0 % 4,907 87.5 % -43.35%
Japan
8.8 %
-- 493 8.8 % -
Others
3.8 %
-- 210 3.8 % -

Managers

Managers TitleAgeSince
Chief Executive Officer 64 00-04-30
Sales & Marketing 64 18-07-31

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 64 00-04-30
Director/Board Member 51 17-02-28
Director/Board Member 56 17-02-28

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 6,003,387 4,726,341 ( 78.73 %) 0 78.73 %

Shareholders

NameEquities%Valuation
Jae-Il Kim
15.88 %
942,710 15.88 % 12 M ₩
Atinum Investment Co., Ltd. (Private Equity)
5.469 %
324,738 5.469 % 4 M ₩
6,540 0.1102 % 81 468 ₩

Company contact information

ANYGEN Co., Ltd.

Room 206, Gwangju Technopark 333 Cheomdanwagi-ro

61008, Gwangju

+

http://www.anygen.com
address Anygen Co., Ltd.(A196300)
  1. Stock Market
  2. Equities
  3. A196300 Stock
  4. Company Anygen Co., Ltd.